Table 3

Incidence of claims per 10 person-years of eligibility by body part and age group over the period between 2006 and 2010

FL (n=1475)MS (n=14 750)Rate ratio (95% CI; FL/MS)Risk difference
n (%)Eligible monthsIncidence (95% CI)n (%)Eligible monthsIncidence (95% CI)
Knee
 18–2421 (6.6)92240.27 (0.16 to 0.39)98 (3.1)127 4560.09 (0.07 to 0.11)2.96 (1.85 to 4.74)*0.18
 25–3445 (9.5)17 1230.32 (0.22 to 0.41)224 (4.7)194 2720.14 (0.12 to 0.16)2.28 (1.65 to 3.14)*0.18
 35–4446 (12.1)16 0130.34 (0.25 to 0.44)228 (6.0)156 0980.18 (0.15 to 0.20)1.97 (1.43 to 2.70)*0.16
 45–5442 (18.0)10 0650.50 (0.35 to 0.65)217 (9.3)94 3390.28 (0.24 to 0.31)1.81 (1.30 to 2.52)*0.22
 55+10 (13.9)32050.37 (0.14 to 0.61)76 (10.6)28 5950.32 (0.25 to 0.39)1.17 (0.61 to 2.27)0.05
Neck
 18–2448 (15.2)85780.67 (0.48 to 0.86)265 (8.4)123 1340.26 (0.23 to 0.29)2.60 (1.91 to 3.54)*0.41
 25–34116 (24.0)15 4310.90 (0.74 to 1.07)632 (13.3)182 1570.42 (0.38 to 0.45)2.17 (1.78 to 2.64)*0.48
 35–44104 (27.4)13 9050.90 (0.73 to 1.07)563 (14.9)146 1580.46 (0.42 to 0.50)1.94 (1.58 to 2.39)*0.44
 45–5459 (25.3)92450.77 (0.57 to 0.96)354 (15.2)90 5220.47 (0.42 to 0.52)1.63 (1.24 to 2.15)*0.30
 55+19 (26.4)28980.79 (0.43 to 1.14)94 (13.1)28 0440.40 (0.32 to 0.48)1.97 (1.19 to 3.20)*0.39
Low back
 18–2478 (24.7)76521.22 (0.95 to 1.49)530 (16.8)115 7620.55 (0.50 to 0.60)2.23 (1.76 to 2.83)*0.67
 25–34175 (36.8)13 7221.53 (1.30 to 1.76)1039 (21.9)170 2580.73 (0.69 to 0.78)2.09 (1.78 to 2.45)*0.80
 35–44155 (40.9)12 0151.55 (1.30 to 1.79)997 (26.3)132 8730.90 (0.84 to 0.96)1.72 (1.45 to 2.04)*0.65
 45–5498 (42.1)80441.46 (1.17 to 1.75)657 (28.2)81 6040.97 (0.89 to 1.04)1.51 (1.22 to 1.87)*0.49
 55+39 (54.2)21182.21 (1.52 to 2.90)187 (26.0)24 8930.90 (0.77 to 1.03)2.45 (1.74 to 3.46)*1.31
Distal arm
 18–2416 (5.1)93260.21 (0.10 to 0.31)102 (3.2)127 2680.10 (0.08 to 0.11)2.14 (1.26 to 3.63)*0.11
 25–3439 (8.2)17 4620.27 (0.18 to 0.35)246 (5.2)193 3590.15 (0.13 to 0.17)1.76 (1.25 to 2.46)*0.12
 35–4441 (10.8)16 1110.31 (0.21 to 0.40)285 (7.5)154 3300.22 (0.20 to 0.25)1.38 (0.99 to 1.91)0.09
 45–5431 (13.3)10 4210.36 (0.23 to 0.48)215 (9.2)94 7900.27 (0.24 to 0.31)1.31 (0.90 to 1.91)0.09
 55+8 (11.1)33160.29 (0.09 to 0.49)58 (8.1)29 0370.24 (0.18 to 0.30)1.21 (0.58 to 2.53)0.05
Shoulder
 18–245 (1.6)96010.06 (0.01 to 0.12)121 (3.8)127 2540.11 (0.09 to 0.13)0.55 (0.22 to 1.34)−0.05
 25–3439 (8.2)17 5400.27 (0.18 to 0.35)223 (4.7)194 0150.14 (0.12 to 0.16)1.93 (1.38 to 2.72)*0.13
 35–4439 (10.3)16 3230.29 (0.20 to 0.38)243 (6.4)155 3640.19 (0.16 to 0.21)1.53 (1.09 to 2.14)*0.10
 45–5428 (12.0)10 3040.33 (0.21 to 0.45)205 (8.8)94 7870.26 (0.22 to 0.30)1.26 (0.85 to 1.86)0.07
 55+11 (15.3)32360.41 (0.17 to 0.65)60 (8.3)29 1730.25 (0.18 to 0.31)1.65 (0.87 to 3.14)0.16
Other LE
 18–2412 (3.8)93430.15 (0.07 to 0.24)146 (4.6)126 3350.14 (0.12 to 0.16)1.11 (0.62 to 2.00)0.01
 25–3425 (5.3)17 7310.17 (0.10 to 0.24)312 (6.6)192 4750.19 (0.17 to 0.22)0.87 (0.58 to 1.31)−0.02
 35–4445 (11.9)16 0520.34 (0.24 to 0.43)308 (8.1)153 8910.24 (0.21 to 0.27)1.40 (1.02 to 1.92)*0.10
 45–5423 (9.9)10 5860.26 (0.15 to 0.37)229 (9.8)94 1460.29 (0.25 to 0.33)0.89 (0.58 to 1.37)−0.03
 55+12 (16.7)32660.44 (0.19 to 0.69)69 (9.6)28 9000.29 (0.22 to 0.35)1.54 (0.83 to 2.84)0.15
Multiple MSDs
 18–2462 (19.6)83930.89 (0.67 to 1.11)293 (9.3)123 7300.28 (0.25 to 0.32)3.12 (2.37 to 4.10)*0.61
 25–34133 (28.0)15 0311.06 (0.88 to 1.24)682 (14.4)183 3170.45 (0.41 to 0.48)2.38 (1.98 to 2.86)*0.61
 35–44135 (35.6)13 5101.20 (1.00 to 1.40)693 (18.3)144 3670.58 (0.53 to 0.62)2.08 (1.73 to 2.50)*0.62
 45–5482 (35.2)87731.12 (0.88 to 1.36)514 (22.1)87 4590.71 (0.64 to 0.77)1.59 (1.26 to 2.01)*0.41
 55+29 (40.3)26671.30 (0.83 to 1.78)131 (18.2)27 1720.58 (0.48 to 0.68)2.26 (1.51 to 3.37)*0.72
  • Incidence=number of individuals with claims per 10 person-years of eligibility during the period; rate ratio: incidence of FL/incidence of MS people; risk difference: the difference between the incidence of FL to the incidence of MS people.

  • *Indicates rate ratios with significant difference between the FL rate and MS cohort rate since the lower bound is above 1.0.

  • FL, floor layers; LE, lower extremity; MS, MarketScan; MSDs, musculoskeletal disorders.